Clinical Trials
3 trialsNCT01655225 2022-04-08
A Study of LY3023414 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01209832 2019-03-18
A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients
Eli Lilly and Company
Phase 1 Terminated
NCT01026415 2014-12-18
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
Seagen Inc.
Phase 1 Completed